Synopsis
This report illustrates how Kable Market Research expects the top ICT spenders in Japan Pharmaceutical industry to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, communications and consulting.
Scope
Identify the top ICT spenders in Japan Pharmaceutical industry.
Gain a view as to how each top spender in Japan Pharmaceutical industry allocates its ICT by IT function.
Get a detailed breakdown of estimated budget allocation of top spenders in Japan Pharmaceutical industry within each of the core areas of ICT spend (hardware, software, IT Services, telecommunications & consulting).
Summary
Why was the report written?
This report presents the output from Kable Market Research’s ICT spend prediction statistical model, a log-linear regression model that provides ICT spending predictions based on a company’s demographic profile. The statistical model has been developed using an extensive collection of survey and interview data Kable Market Research has conducted with ICT decision makers on their ICT spending, as well as the insight of our analyst team.
What makes this report unique and essential to read?
The predictions were formulated in November 2012 following a large survey of ICT decision makers. Estimated trends in ICT spending have been identified through to the end of 2013 following feedback from respondents on their forthcoming investment plans.
Reasons To Buy
NA
Table of Contents
1 Top-level ICT budget breakdowns
1.1 Introduction
2 Top ICT spenders
3 MediPal Holdings Corporation
3.1 Estimated ICT budget breakdown by function
3.2 Estimated external ICT budget allocation by core technology area
3.3 Detailed ICT budget allocations
3.3.1 Estimated hardware budget breakdown
3.3.2 Estimated software budget breakdown by technology
3.3.3 Estimated software budget breakdown by type
3.3.4 Estimated IT services budget breakdown
3.3.5 Estimated IT consulting services budget breakdown
3.3.6 Estimated telecommunications budget breakdown
4 Alfresa Holdings Corporation
4.1 Estimated ICT budget breakdown by function
4.2 Estimated external ICT budget allocation by core technology area
4.3 Detailed ICT budget allocations
4.3.1 Estimated hardware budget breakdown
4.3.2 Estimated software budget breakdown by technology
4.3.3 Estimated software budget breakdown by type
4.3.4 Estimated IT services budget breakdown
4.3.5 Estimated IT consulting services budget breakdown
4.3.6 Estimated telecommunications budget breakdown
5 Suzuken Co. Ltd.
5.1 Estimated ICT budget breakdown by function
5.2 Estimated external ICT budget allocation by core technology area
5.3 Detailed ICT budget allocations
5.3.1 Estimated hardware budget breakdown
5.3.2 Estimated software budget breakdown by technology
5.3.3 Estimated software budget breakdown by type
5.3.4 Estimated IT services budget breakdown
5.3.5 Estimated IT consulting services budget breakdown
5.3.6 Estimated telecommunications budget breakdown
6 Takeda Pharmaceutical Co. Ltd.
6.1 Estimated ICT budget breakdown by function
6.2 Estimated external ICT budget allocation by core technology area
6.3 Detailed ICT budget allocations
6.3.1 Estimated hardware budget breakdown
6.3.2 Estimated software budget breakdown by technology
6.3.3 Estimated software budget breakdown by type
6.3.4 Estimated IT services budget breakdown
6.3.5 Estimated IT consulting services budget breakdown
6.3.6 Estimated telecommunications budget breakdown
7 Otsuka Holdings Co. Ltd.
7.1 Estimated ICT budget breakdown by function
7.2 Estimated external ICT budget allocation by core technology area
7.3 Detailed ICT budget allocations
7.3.1 Estimated hardware budget breakdown
7.3.2 Estimated software budget breakdown by technology
7.3.3 Estimated software budget breakdown by type
7.3.4 Estimated IT services budget breakdown
7.3.5 Estimated IT consulting services budget breakdown
7.3.6 Estimated telecommunications budget breakdown
8 Daiichi Sankyo Co. Ltd.
8.1 Estimated ICT budget breakdown by function
8.2 Estimated external ICT budget allocation by core technology area
8.3 Detailed ICT budget allocations
8.3.1 Estimated hardware budget breakdown
8.3.2 Estimated software budget breakdown by technology
8.3.3 Estimated software budget breakdown by type
8.3.4 Estimated IT services budget breakdown
8.3.5 Estimated IT consulting services budget breakdown
8.3.6 Estimated telecommunications budget breakdown
9 Astellas Pharma Inc.
9.1 Estimated ICT budget breakdown by function
9.2 Estimated external ICT budget allocation by core technology area
9.3 Detailed ICT budget allocations
9.3.1 Estimated hardware budget breakdown
9.3.2 Estimated software budget breakdown by technology
9.3.3 Estimated software budget breakdown by type
9.3.4 Estimated IT services budget breakdown
9.3.5 Estimated IT consulting services budget breakdown
9.3.6 Estimated telecommunications budget breakdown
10 Chugai Pharmaceutical Co. Ltd.
10.1 Estimated ICT budget breakdown by function
10.2 Estimated external ICT budget allocation by core technology area
10.3 Detailed ICT budget allocations
10.3.1 Estimated hardware budget breakdown
10.3.2 Estimated software budget breakdown by technology
10.3.3 Estimated software budget breakdown by type
10.3.4 Estimated IT services budget breakdown
10.3.5 Estimated IT consulting services budget breakdown
10.3.6 Estimated telecommunications budget breakdown
11 Eisai Co. Ltd.
11.1 Estimated ICT budget breakdown by function
11.2 Estimated external ICT budget allocation by core technology area
11.3 Detailed ICT budget allocations
11.3.1 Estimated hardware budget breakdown
11.3.2 Estimated software budget breakdown by technology
11.3.3 Estimated software budget breakdown by type
11.3.4 Estimated IT services budget breakdown
11.3.5 Estimated IT consulting services budget breakdown
11.3.6 Estimated telecommunications budget breakdown
12 Mitsubishi Tanabe Pharma Corporation
12.1 Estimated ICT budget breakdown by function
12.2 Estimated external ICT budget allocation by core technology area
12.3 Detailed ICT budget allocations
12.3.1 Estimated hardware budget breakdown
12.3.2 Estimated software budget breakdown by technology
12.3.3 Estimated software budget breakdown by type
12.3.4 Estimated IT services budget breakdown
12.3.5 Estimated IT consulting services budget breakdown
12.3.6 Estimated telecommunications budget breakdown
13 Appendix
13.1 Definitions
13.2 Further reading
13.3 Contact the authors
List Of Tables
Table 1: Top ICT spenders in the Japanese pharmaceutical industry
Table 2: MediPal Holdings Corporation will spend an estimated ¥12.9 billion on its data centre
Table 3: MediPal Holdings Corporation will spend an estimated ¥12.7 billion on hardware
Table 4: MediPal Holdings Corporation will spend an estimated ¥2.5 billion on clients
Table 5: MediPal Holdings Corporation will spend an estimated ¥2.2 billion on enterprise applications
Table 6: MediPal Holdings Corporation will spend an estimated ¥4.1 billion on software licenses
Table 7: MediPal Holdings Corporation will spend an estimated ¥1.9 billion on application development & integration
Table 8: MediPal Holdings Corporation will spend an estimated ¥2.2 billion on systems planning & design.
Table 9: MediPal Holdings Corporation will spend an estimated ¥1.5 billion on fixed voice
Table 10: Alfresa Holdings Corporation will spend an estimated ¥11 billion on its data centre
Table 11: Alfresa Holdings Corporation will spend an estimated ¥10.8 billion on hardware
Table 12: Alfresa Holdings Corporation will spend an estimated ¥2.1 billion on clients
Table 13: Alfresa Holdings Corporation will spend an estimated ¥1.8 billion on enterprise applications
Table 14: Alfresa Holdings Corporation will spend an estimated ¥3.5 billion on software licenses
Table 15: Alfresa Holdings Corporation will spend an estimated ¥1.6 billion on application development & integration
Table 16: Alfresa Holdings Corporation will spend an estimated ¥1.8 billion on systems planning & design.
Table 17: Alfresa Holdings Corporation will spend an estimated ¥1.2 billion on fixed voice
Table 18: Suzuken Co. Ltd. will spend an estimated ¥8.9 billion on its data centre
Table 19: Suzuken Co. Ltd. will spend an estimated ¥8.7 billion on hardware
Table 20: Suzuken Co. Ltd. will spend an estimated ¥1.7 billion on clients
Table 21: Suzuken Co. Ltd. will spend an estimated ¥1.5 billion on enterprise applications
Table 22: Suzuken Co. Ltd. will spend an estimated ¥2.8 billion on software licenses
Table 23: Suzuken Co. Ltd. will spend an estimated ¥1.3 billion on application development & integration
Table 24: Suzuken Co. Ltd. will spend an estimated ¥1.5 billion on systems planning & design
Table 25: Suzuken Co. Ltd. will spend an estimated ¥996m on fixed voice
Table 26: Takeda Pharmaceutical Co. Ltd. will spend an estimated ¥7.6 billion on its data centre
Table 27: Takeda Pharmaceutical Co. Ltd. will spend an estimated ¥7.5 billion on hardware
Table 28: Takeda Pharmaceutical Co. Ltd. will spend an estimated ¥1.5 billion on clients
Table 29: Takeda Pharmaceutical Co. Ltd. will spend an estimated ¥1.3 billion on enterprise applications
Table 30: Takeda Pharmaceutical Co. Ltd. will spend an estimated ¥2.4 billion on software licenses
Table 31: Takeda Pharmaceutical Co. Ltd. will spend an estimated ¥1.1 billion on application development & integration
Table 32: Takeda Pharmaceutical Co. Ltd. will spend an estimated ¥1.3 billion on systems planning & design..
Table 33: Takeda Pharmaceutical Co. Ltd. will spend an estimated ¥859m on fixed voice
Table 34: Otsuka Holdings Co. Ltd. will spend an estimated ¥5.9 billion on its data centre
Table 35: Otsuka Holdings Co. Ltd. will spend an estimated ¥5.8 billion on hardware
Table 36: Otsuka Holdings Co. Ltd. will spend an estimated ¥1.1 billion on clients
Table 37: Otsuka Holdings Co. Ltd. will spend an estimated ¥991m on enterprise applications
Table 38: Otsuka Holdings Co. Ltd. will spend an estimated ¥1.9 billion on software licenses
Table 39: Otsuka Holdings Co. Ltd. will spend an estimated ¥853 on application development & integration
Table 40: Otsuka Holdings Co. Ltd. will spend an estimated ¥991m on systems planning & design
Table 41: Otsuka Holdings Co. Ltd. will spend an estimated ¥662m on fixed voice
Table 42: Daiichi Sankyo Co. Ltd. will spend an estimated ¥4.9 billion on its data centre
Table 43: Daiichi Sankyo Co. Ltd. will spend an estimated ¥4.8 billion on hardware
Table 44: Daiichi Sankyo Co. Ltd. will spend an estimated ¥946m on clients
Table 45: Daiichi Sankyo Co. Ltd. will spend an estimated ¥824m on enterprise applications
Table 46: Daiichi Sankyo Co. Ltd. will spend an estimated ¥1.6 billion on software licenses
Table 47: Daiichi Sankyo Co. Ltd. will spend an estimated ¥709m on application development & integration
Table 48: Daiichi Sankyo Co. Ltd. will spend an estimated ¥824m on systems planning & design
Table 49: Daiichi Sankyo Co. Ltd. will spend an estimated ¥551m on fixed voice
Table 50: Astellas Pharma Inc. will spend an estimated ¥4.8 billion on its data centre
Table 51: Astellas Pharma Inc. will spend an estimated ¥4.7 billion on hardware
Table 52: Astellas Pharma Inc. will spend an estimated ¥917m on clients
Table 53: Astellas Pharma Inc. will spend an estimated ¥799m on enterprise applications
Table 54: Astellas Pharma Inc. will spend an estimated ¥1.5 billion on software licenses
Table 55: Astellas Pharma Inc. will spend an estimated ¥687m on application development & integration
Table 56: Astellas Pharma Inc. will spend an estimated ¥799m on systems planning & design
Table 57: Astellas Pharma Inc. will spend an estimated ¥534m on fixed voice
Table 58: Chugai Pharmaceutical Co. Ltd. will spend an estimated ¥3 billion on its data centre
Table 59: Chugai Pharmaceutical Co. Ltd. will spend an estimated ¥3 billion on hardware
Table 60: Chugai Pharmaceutical Co. Ltd. will spend an estimated ¥590m on clients
Table 61: Chugai Pharmaceutical Co. Ltd. will spend an estimated ¥532m on enterprise applications
Table 62: Chugai Pharmaceutical Co. Ltd. will spend an estimated ¥1 billion on software licenses
Table 63: Chugai Pharmaceutical Co. Ltd. will spend an estimated ¥453m on application development & integration
Table 64: Chugai Pharmaceutical Co. Ltd. will spend an estimated ¥494m on systems planning & design.
Table 65: Chugai Pharmaceutical Co. Ltd. will spend an estimated ¥350m on fixed voice
Table 66: Eisai Co. Ltd. will spend an estimated ¥2.6 billion on its data centre
Table 67: Eisai Co. Ltd. will spend an estimated ¥2.6 billion on hardware
Table 68: Eisai Co. Ltd. will spend an estimated ¥506m on clients
Table 69: Eisai Co. Ltd. will spend an estimated ¥441m on enterprise applications
Table 70: Eisai Co. Ltd. will spend an estimated ¥835m on software licenses
Table 71: Eisai Co. Ltd. will spend an estimated ¥380m on application development & integration
Table 72: Eisai Co. Ltd. will spend an estimated ¥441m on systems planning & design
Table 73: Eisai Co. Ltd. will spend an estimated ¥295m on fixed voice
Table 74: Mitsubishi Tanabe Pharma Corporation will spend an estimated ¥2.4 billion on its data centre..
Table 75: Mitsubishi Tanabe Pharma Corporation will spend an estimated ¥2.4 billion on hardware
Table 76: Mitsubishi Tanabe Pharma Corporation will spend an estimated ¥462m on clients
Table 77: Mitsubishi Tanabe Pharma Corporation will spend an estimated ¥16m on enterprise applications
Table 78: Mitsubishi Tanabe Pharma Corporation will spend an estimated ¥761m on software licenses
Table 79: Mitsubishi Tanabe Pharma Corporation will spend an estimated ¥346m on application development & integration
Table 80: Mitsubishi Tanabe Pharma Corporation will spend an estimated ¥402m on systems planning & design..
Table 81: Mitsubishi Tanabe Pharma Corporation will spend an estimated ¥269m on fixed voice
List Of Figures
Figure 1: Top ICT spenders in the Japanese pharmaceutical industry
